SEC-sourced researchBeta
IMDX
Insight Molecular Diagnostics Inc.
Company comparison ↗
Data passport
- CIK
- 0001642380
- Exchange
- Nasdaq
- Business activity
- — · SIC 2835
- Financial inputs
- 6/6
- Filing date
- Sep 21, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 1,881,000.0000 | Mar 26, 2026 |
| December 2025 | 4,055,000.0000 | Mar 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 4,055,000.0000 | -50,222,000.0000 | -22,184,000.0000 | 25,756,000.0000 | 57,220,000.0000 | Mar 26, 2026 |
| December 2024 | 1,881,000.0000 | -60,663,000.0000 | -20,689,000.0000 | 35,081,000.0000 | 47,355,000.0000 | Mar 26, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $4.06M | December 2025 | Mar 26, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.88M | December 2024 | Mar 26, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$50.22M | December 2025 | Mar 26, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$22.18M | December 2025 | Mar 26, 2026 | 10-K |
| Total assetsAssets | $25.76M | December 2025 | Mar 26, 2026 | 10-K |
| Total liabilitiesLiabilities | $57.22M | December 2025 | Mar 26, 2026 | 10-K |